📰 Antitrust Division News
Page 38 - Antitrust Division News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Antitrust Division. Real-time updates on events, politics, business and more.
August 30, 2023
The Federal Trade Commission (FTC) and Department of Justice (DOJ), Antitrust Division announced that they will hold three workshops regarding their jointly issued Draft Merger...
August 25, 2023
The Federal Trade Commission’s (FTC) recent multipronged challenge to EQT Corporation’s acquisition from the Quantum Energy Partners private equity investment group “marks the FTC’s...
August 25, 2023
An oncologist and former president of Florida Cancer Specialists & Research Institute LLC has pleaded guilty to a conspiracy charge in what authorities say was a scheme to limit cancer-care competition in Southwest Florida.
August 24, 2023
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
August 24, 2023
On August 16, 2023, the US Federal Trade Commission (“FTC”) brought its first enforcement action under Section 8 of the Clayton Act in 40 years. At the same time, the US Department of...
August 24, 2023
Former Allen County-based auctioneer Mackie Shelton, whose career came to an end after a federal bid-rigging conviction, was ordered Wednesday to serve an 18-month prison sentence after a judge revoked
August 23, 2023
The company in an exchange notification said that it has entered into a three-year deferred prosecution agreement, and if the company adheres to the terms of the agreement, including the payment of $30 million, payable in six installments, the DOJ will dismiss the pending superseding indictment.
August 23, 2023
For the first time in 40 years, the Federal Trade Commission (FTC) has taken action to enforce Section 8 of the Clayton Act, which prohibits so-called interlocking directorates.
August 23, 2023
The US Justice Department announced deferred prosecution agreements resolving criminal antitrust charges against Teva Pharmaceuticals USA, Inc. (a subsidiary of Israel’s Teva) and Glenmark Pharmaceuticals Inc. As part of those agreements, both companies will divest a key business line involved in the misconduct, a generic cholesterol drug, pravastatin, and as an additional remedial measure, Teva […]
August 22, 2023
The two companies both agreed to sell off their operations making the cholesterol drug pravastatin. Companies typically pay criminal fines to settle antitrust…